Medical School Sawai Man Singh Med Coll, Rajasthan Univ, Jaipur, Rajasthan, India Graduated: 1969
Procedures:
Cardiac Stress Test Arthrocentesis Echocardiogram Electrocardiogram (EKG or ECG) Vaccine Administration
Conditions:
Congenital Anomalies of the Heart Abdominal Hernia Abnormal Vaginal Bleeding Acne Acute Bronchitis
Languages:
English
Description:
Dr. Mehta graduated from the Sawai Man Singh Med Coll, Rajasthan Univ, Jaipur, Rajasthan, India in 1969. He works in Independence, OH and 1 other location and specializes in Internal Medicine and Cardiovascular Disease. Dr. Mehta is affiliated with Hillcrest Hospital, Marymount Hospital and St Vincent Charity Medical Center.
Dr. Mehta graduated from the Grant Med Coll, Univ of Mumbai, Mumbai, Maharashtra, India in 1982. He works in Jackson, MI and specializes in Cardiovascular Disease. Dr. Mehta is affiliated with Allegiance Health and Sparrow Hospital.
Carlo Licata - Pasadena CA Rajendra Mehta - Reno NV Manoranjan Misra - Reno NV
Assignee:
Maxim LLC - Pasadena CA
International Classification:
C02F 142
US Classification:
210661, 210688
Abstract:
A method of removing both Sr and Cs from an alkaline solution having a pH between about 9 to 14 includes providing a keratin protein from essentially a fiber portion separated from a quill portion of a poultry feather. A slurry is made of the keratin protein and the alkaline solution and is treated ultrasonically. The Sr and Cs may each be present in the alkaline solution at least at about 5 ppb. The keratin protein is contacted with the Sr and Cs by mechanical agitation at a temperature between about 20 to 90Â C. and at a pressure not greater than about 10 psi. A supernatant produced in the step of contacting is then filtered.
1Α-Hydroxyvitamin D5, Its Synthesis And Use In Cancer Prevention
Robert M. Moriarty - Oak Park IL, US Raju A. Penmasta - Bolingbrook IL, US Liang Guo - Bolingbrook IL, US Munagala S. Rao - Westmont IL, US Rajendra G. Mehta - Orland Park IL, US
Assignee:
OncQuest, Inc. - Chicago IL
International Classification:
A61K031/59 C07C401/00
US Classification:
514167, 552653
Abstract:
A compound of formula I: wherein R1 is hydrogen, R2 is —CH, R3 is —CH, and R4 is hydrogen, useful in cancer prevention and therapy.
Compositions And Methods To Prevent Cancer With Cupredoxins
Tapas Das Gupta - River Forest IL, US Rajendra G. Mehta - Orland Park IL, US Rajeshwari Mehta - Orland Park IL, US Craig Beattie - Chicago IL, US
Assignee:
CDG Therapeutics, Inc. - Elk Grove Village IL
International Classification:
C07K 14/00
US Classification:
514 1, 530300
Abstract:
The present invention relates to compositions and methods comprising chemopreventive agents that may be cupredoxin(s) or variants, derivatives and structural equivalents of cupredoxins, and at least one other chemopreventive agent. Specifically, these compositions may comprise azurin from , and/or the 50-77 residue region of azurin (p28). The at least one other chemopreventive agent may comprise an antiestrogen such as Tamoxifen. The compositions of the invention may be used to prevent the development of premalignant lesions in mammalian cells, tissues and animals, and thus prevent cancer.
Carlo Licata - Pasadena CA, US Rajendra Mehta - Reno NV, US Manorangan Misra - Reno NV, US
Assignee:
MAXIM, LLC, a limited liability corporation
International Classification:
C02F001/28
US Classification:
210/661000, 210/688000
Abstract:
A method of removing a heavy metal from a composition comprises: (1) providing a fibrous protein fiber; (2) agitating the fibrous protein fiber; (3) making a slurry of the agitated fibrous protein fiber; (4) contacting the agitated fibrous protein fiber slurry with a composition containing a heavy metal ion or a heavy metal ion complex; and (5) filtering a supernatant produced in step (4) to remove the heavy metal from the composition. The fibrous protein of the fibrous protein fiber can be selected from the group consisting of keratins, collagens, fibrins, and elastins. Typically, the fibrous protein of the fibrous protein fiber is a keratin. Yet another aspect of the present invention is a method of removing a heavy metal from a composition, comprising: (1) providing a keratin protein fiber; (2) agitating the keratin protein fiber by a process selected from the group consisting of ultrasound and mechanical mixing; (3) treating the keratin protein fiber with alkali at a pH of between about 9 to about 14; (4) packing the agitated alkali treated keratin protein fiber into a column; (5) passing the composition through the column under pressure to remove the heavy metal from the composition; (6) desorbing adsorbed heavy metal from the column by treatment with an acid; (7) washing the column for a first time; (8) regenerating the column by passing alkali through the column; and (9) washing the column for a second time.
Gary Groce, Larry Pedersbeck, Craig Jensen, Danny Chapman, Muriel Nelson, Bill Lembcke, Pamela Jorgensen, Diane Olson, Rick Bettmeng, Barbara Jensen, David Lundin